Mutya Harsch - 20 Mar 2023 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Chief Legal Officer and GC
Signature
/s/ Mutya Harsch
Issuer symbol
VYNE
Transactions as of
20 Mar 2023
Net transactions value
+$25,000
Form type
4
Filing time
22 Mar 2023, 16:01:41 UTC
Previous filing
04 Jan 2023
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Purchase $25,000 +10,000 +79% $2.50 22,721 20 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split.